2018 Board Review Pre-Test:
HFpEF, Assessment, Treatment and Outcomes

HFpEF, Assessment, Treatment and Outcomes - Sanjiv J. Shah, MD

Please complete this brief Pre-Test to give a baseline for learning.

Question Title

* 1. Which of the following treatments has been shown to prevent HFpEF in at-risk patients?

A. Chlorthalidone

B. Spironolactone

C. Implantable PA monitor

D. Ivabradine

E. Verapamil

Question Title

* 2. Which of the following treatments has been shown to reduce HF hospitalization in patients with HFpEF?

A. Candesartan

B. Irbesartan

C. Isosorbide mononitrate

D. Spironolactone

E. Empagliflozin

Question Title

* 3. Which of the following treatments has been shown to improve exercise tolerance in patients with HFpEF in a randomized controlled trial?

A. Sildenafil

B. Spironolactone

C. Implantable PA monitor

D. Caloric restriction

E. Verapamil

Question Title

* 4.

Which of the following ECG findings would be characteristic in a patient with HFpEF, LV hypertrophy, and the LV longitudinal strain pattern shown above?

A. Deep T wave inversions

B. Low voltage

C. Epsilon wave

D. Right axis deviation

E. Diffuse ST elevations

Question Title

* 5. Please provide your first and last name.
Pre-test questions will not be scored, your name is required solely to confirm completion.

First Name *

Last Name